PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter ...

Bristol Myers Squibb Co. will sell its pill for psoriasis directly to cash-paying patients at a more than 80% discount to the drug’s list price, following President Donald Trump’s demand that ...

Schizophrenia care is shifting. In this article, Dr. Stella Sarraf, founder and CEO of Spinogenix, and Dr. David Walling, ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Compared with sham therapy, 12 days of personalized treatment with high-definition transcranial direct current stimulation ...

Bristol Myers reports positive phase III results for iberdomide in multiple myeloma, advancing its CELMoD pipeline and ...

In his attempts to reduce drug prices in the U.S., President Donald Trump’s message to the rest of the world has been clear: ...

Bristol-Myers Squibb is the latest drugmaker to raise drug prices abroad to align with President Donald Trump's "most favored nation" drug pricing ...

Why it matters: That only gets halfway toward Trump's goal of ending what he calls "global freeloading" and getting other developed countries to foot more of the cost while lowering costs for ...

Big drug companies so far are responding to President Trump's demand they commit to his "most favored nation" pricing policy ...

The collapse in value of many biotechs over the past few years has created an opportunity for specialists like Xoma to “do ...

US pharma major Bristol Myers Squibb revealed plans to launch Cobenfy (xanomeline and trospium chloride) in the UK in 2026.